C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes

Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
12/2004
12/09/2004	WO2004106506A2 Crystallographic structure of trypanosoma cruzi proline racemase (tcpraca) and uses thereof
12/09/2004	WO2004106489A2 Nematode GS-like sequences
12/09/2004	WO2004106365A2 Modulatory peptide motifs for inducing th1 or th2 immune response
12/09/2004	WO2004093919A3 Target for cancer therapy and drug discovery
12/09/2004	WO2004087905A3 Protein tyrosine phosphatase and inhibitors thereof
12/09/2004	WO2004082564A3 Coated enzyme granules
12/09/2004	WO2004081168A3 A class of metacaspases
12/09/2004	WO2004079326A3 Anaplastic lymphoma kinase assay, reagents and compositions thereof
12/09/2004	WO2004076615A3 Immunomodulating probiotic compounds
12/09/2004	WO2004067548A3 Chemically modified metabolites of regulatory peptides and methods of producing and using same
12/09/2004	WO2004063360A3 Improved method for the production of vitamin b12
12/09/2004	WO2004062618A3 Method for in vivo regulation of cardiac muscle contractility
12/09/2004	WO2004031396A3 Cell-free production of glucosamine
12/09/2004	WO2004018693A3 Method for the production of ketocarotinoids in flower petals on plants
12/09/2004	WO2004017728A3 Methods
12/09/2004	WO2003087301A3 Methods and compositions for dna manipulation
12/09/2004	WO2003072114A9 Vascular therapeutics
12/09/2004	WO2003057835A3 Pak5-related compositions and methods
12/09/2004	WO2003056897A3 Highly phosphorylated acid beta-glucocerebrosidase and methods of treating gaucher's disease
12/09/2004	WO2002090300A3 Nucleic acids and proteins with thioredoxin reductase activity
12/09/2004	WO2001096529A3 Acetyl glucosaminyl inositol deacetylase, a mycothiol biosynthetic enzyme, and methods of use
12/09/2004	US20040250322 Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene
12/09/2004	US20040250315 Sd1 gene involved in plants semidwarfing and utilization thereof
12/09/2004	US20040250309 Novel compositions with chitinase activity
12/09/2004	US20040250300 Expression of proteins in milk
12/09/2004	US20040250299 Compound screening method
12/09/2004	US20040249219 Method of making teprenone
12/09/2004	US20040249131 Mycobacterial sulfation pathway proteins and methods of use thereof
12/09/2004	US20040248830 Agents that regulate apoptosis
12/09/2004	US20040248813 Compounds and methods for the modulation of cd154
12/09/2004	US20040248785 mutant factor VIII has procoagulant activity; increased half-life; substituted amino acid(s) in the A2 domain
12/09/2004	US20040248302 Brassica pyruvate dehydrogenase kinase gene
12/09/2004	US20040248276 Novel aconitase
12/09/2004	US20040248274 Enzymatic polypeptide which generates alpha -h- alpha -amino acid amides for use in preparation of pharmaceuticals and alpha -H- alpha -amino acids
12/09/2004	US20040248273 Subtilase variants
12/09/2004	US20040248272 Heat-labile desoxyribonuclease I variants
12/09/2004	US20040248270 Process for producing concentrated/purified protein using clay mineral composition
12/09/2004	US20040248264 Nucleotide sequence coding phosphotransferase for use in the transformation and propagation of transgenic corynebacterium; fermentation of lysine for use in preparing nutrient broths, animal feeds and cosmetics
12/09/2004	US20040248262 Nucleotide sequences coding lysosomal protein for use treatment of brain and muscular disorders
12/09/2004	US20040248261 Feline IL-12 single chain proteins and nucleic acid molecules
12/09/2004	US20040248253 Methods and compositions for polypeptide engineering
12/09/2004	US20040248250 Method for modifying enzyme and oxidoreductive variant
12/09/2004	US20040248244 ATM related kinase ATX, nucleic acids encoding same and methods of use
12/09/2004	US20040248243 Lipid metabolizing polypeptide for use in identifying modulators for treatment and prevention of cancer, nervous system, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders
12/09/2004	US20040248242 47153, a human glycosyltransferase family member and uses therefor
12/09/2004	US20040248238 Method for increasing the solubility, expression rate and the acitivity of proteins during recombinant production
12/09/2004	US20040248231 Using reduction in beta site amyloid precursor protein cleaving enzyme activity, manifested as decreased beta amyloid peptides production, as diagnostic indicator of enzyme inhibition; for use in treatment of amyloid deposition disorders
12/09/2004	US20040248230 Stabilization of t4 endonuclease v
12/09/2004	US20040248177 Human hypercholesterolemia causal gene and use thereof
12/09/2004	US20040248168 Nucleotide sequences coding homeodomain-interacting protein kinase (HIPK) for use as tool in identifying antisense agent for use in treatment of nervous system and brain disorders
12/09/2004	US20040248160 Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor
12/09/2004	US20040248159 Plant farnesyltransferases
12/09/2004	US20040248145 Using vector transformation to generate transgenic cells which overexpress an enzyme which specifically digests RNA/DNA hybrids; gene expression inhibition via nuclease digestion and antisense oligonucleotide exposure
12/09/2004	US20040248143 Generating novel polypeptides via non-stochastic polynucleotide site-saturation mutagenesis; protein bioengineering
12/09/2004	US20040248079 Detecting presence of nucleoside diphosphate in a sample comprising monitoring dephosphorylation of phosphoenzyme form of nucleoside diphosphate kinase (NDPK); bioenergetics and metabolism
12/09/2004	US20040247691 wound healing and tissue forming compositions with suitable cells affixed to prosthetic devices; microbeads are prepared by coagulation and emulsification of fibrinogen, thrombin and factor XIII without gluteraldehyde as a crosslinking agent
12/09/2004	US20040247618 Nutrient absorption enhancing compositions and methods
12/09/2004	US20040247613 A nucleic acid expression vector encodes the catalytic subunit of human telomerase reverse transcriptase (hTRT); immunostimulants; anticarcinogenic agents; gene therapy
12/09/2004	US20040247603 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation
12/09/2004	US20040247587 Alpha-glycated amino acid releasing enzyme
12/09/2004	US20040247586 Parkin-associated complex for protecting post-mitotic neurons from excitotoxicity and uses thereof
12/09/2004	US20040247585 Recombinant alpha-galactosidase a therapy for fabry disease
12/09/2004	US20040247583 Capable of producing d-pseudoephedrine by acting on l-2-methylaminopropiophenone; a nucleic acid coding the enzyme, a microorganism producing the enzyme, and producing an optically active aminoalcohol using them
12/09/2004	US20040247577 Administering an immunogen that elicits an immune response to heparanase; preferably the immunogen is an antigen presenting cell (such as a dendritic cell), displaying heparanase or a fragment thereof on the surface
12/09/2004	DE102004019852A1 New modified sarcosine oxidase, useful for assaying creatinine, e.g. for diagnosis of kidney disease, has improved stability under acidic conditions, also new DNA that encodes it
12/09/2004	CA2527571A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
12/09/2004	CA2527115A1 Wheat plants having increased tolerance to imidazolinone herbicides
12/09/2004	CA2525681A1 Crystals and structures of c-abl tyrosine kinase domain
12/09/2004	CA2524454A1 Enzyme with xylanase activity at acidic ph
12/08/2004	EP1484408A1 Human kinase proteins and polynucleotides encoding the same
12/08/2004	EP1484407A1 Method of controlling ethanol production and mass production of lactic acid and transformant therefor
12/08/2004	EP1484403A1 Gene participating in the synthesis of brassinosteroid
12/08/2004	EP1484395A1 Transposon being functional in mammals
12/08/2004	EP1484392A1 Diacylglycerol acyltransferase genes, proteins and uses thereof
12/08/2004	EP1483581A2 Population based assessments and means to rank the relative immunogenicity of proteins
12/08/2004	EP1483393A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae
12/08/2004	EP1483392A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae
12/08/2004	EP1483390A2 Transgenic plants synthesising high amylose starch
12/08/2004	EP1483388A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
12/08/2004	EP1483384A2 Method for overexpression of zwitterionic polysaccharides
12/08/2004	EP1483382A1 Alleles of the acea gene from coryneform bacteria
12/08/2004	EP1483381A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
12/08/2004	EP1483380A2 Recombinant protein c variants
12/08/2004	EP1483378A2 Recycling system for manipulation of intracellular nadh availability
12/08/2004	EP1483282A1 RIBOZYMES WITH BROAD tRNA AMINOACYLATION ACTIVITY
12/08/2004	EP1483254A1 Resistance-repellent retroviral protease inhibitors
12/08/2004	EP1482982A1 Conjugates of the c domain of human gelatinase a and polyethylene glycol, methods of purification and uses thereof
12/08/2004	EP1482969A2 Purifying process of soluble proteins of the l. obliqua bristles through prothrombin activation; process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction ii, n-terminal and internal fragments sequence
12/08/2004	EP1482961A2 Use of soluble fgl2 as an immunosuppressant
12/08/2004	EP1482901A1 Method for colouring keratin fibres
12/08/2004	EP1482779A2 Heat stable mutants of starch biosynthesis enzymes
12/08/2004	EP1421175A4 Polymer stabilized proteinases
12/08/2004	EP1290147A4 Directed evolution of oxidase enzymes
12/08/2004	EP1266033A4 Method of reverse transcription using bacillus steraothermophilus or thermoactinomyces vulgaris dna polymerase
12/08/2004	EP1120461B1 Process for producing copolymerized polyester
12/08/2004	EP1114040B1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
12/08/2004	EP1015015A4 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY
12/08/2004	EP1012340A4 Genotyping of human cyp3a4
12/08/2004	EP1009767B1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
12/08/2004	EP0991765B1 Resistance marker for monocotyledons

1 ... 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 ... 1416